AKT1 and Miyoshi myopathy: As shown in Figure 7a,b, while serum induced strong and sustained activation of AKT and ERK1/2 in both NCI-H2052 and MSTO-211H DMSO-treated control MM cells, CAPS significantly inhibited the activation of both signaling pathways.